“…The rate of cholangitis after ERCP varies from 0.08% to 5% (296)(297)(298)(299)(313)(314)(315)(316)(317)(318)(319)(320)(321)(322). Post-ERCP cholangitis is defined by a typical clinical picture (temperature of Ͼ38°C, upper abdominal colicky pain, and cholestasis/jaundice) without evidence of other concomitant infections and with or without positive bile cultures obtained during biliary drainage (299).…”
Section: Diagnostic and Therapeutic Upper Gastrointestinal Endoscopymentioning
SUMMARY
Flexible endoscopy is a widely used diagnostic and therapeutic procedure. Contaminated endoscopes are the medical devices frequently associated with outbreaks of health care-associated infections. Accurate reprocessing of flexible endoscopes involves cleaning and high-level disinfection followed by rinsing and drying before storage. Most contemporary flexible endoscopes cannot be heat sterilized and are designed with multiple channels, which are difficult to clean and disinfect. The ability of bacteria to form biofilms on the inner channel surfaces can contribute to failure of the decontamination process. Implementation of microbiological surveillance of endoscope reprocessing is appropriate to detect early colonization and biofilm formation in the endoscope and to prevent contamination and infection in patients after endoscopic procedures. This review presents an overview of the infections and cross-contaminations related to flexible gastrointestinal endoscopy and bronchoscopy and illustrates the impact of biofilm on endoscope reprocessing and postendoscopic infection.
“…The rate of cholangitis after ERCP varies from 0.08% to 5% (296)(297)(298)(299)(313)(314)(315)(316)(317)(318)(319)(320)(321)(322). Post-ERCP cholangitis is defined by a typical clinical picture (temperature of Ͼ38°C, upper abdominal colicky pain, and cholestasis/jaundice) without evidence of other concomitant infections and with or without positive bile cultures obtained during biliary drainage (299).…”
Section: Diagnostic and Therapeutic Upper Gastrointestinal Endoscopymentioning
SUMMARY
Flexible endoscopy is a widely used diagnostic and therapeutic procedure. Contaminated endoscopes are the medical devices frequently associated with outbreaks of health care-associated infections. Accurate reprocessing of flexible endoscopes involves cleaning and high-level disinfection followed by rinsing and drying before storage. Most contemporary flexible endoscopes cannot be heat sterilized and are designed with multiple channels, which are difficult to clean and disinfect. The ability of bacteria to form biofilms on the inner channel surfaces can contribute to failure of the decontamination process. Implementation of microbiological surveillance of endoscope reprocessing is appropriate to detect early colonization and biofilm formation in the endoscope and to prevent contamination and infection in patients after endoscopic procedures. This review presents an overview of the infections and cross-contaminations related to flexible gastrointestinal endoscopy and bronchoscopy and illustrates the impact of biofilm on endoscope reprocessing and postendoscopic infection.
“…The situation is different in old patients or those with status post-cholecystectomy, especially with the advent of laparoscopic cholecystectomy, where ES may be the first choice of treatment. If ES alone is not sufficient, stent placement may obviate the need for surgery, which has a higher morbidity and mortality in this situation [19][20][21][22][23][24][25]. Patients with a T tube and retained stone in the common bile duct after cholecystectomy need to be considered differently as there is a possibility in these patients of extracting stones through the T tube.…”
Therapeutic Biliary Endoscopy (TBE) is becoming a popular mode of treatment for patients with obstructive jaundice. This paper highlights our early experience of TBE at Armed Forces Medical College and Command Hospital (sq, Pune with this mode of treatment. TBE was used as a primary therapeutic option in 46 patients with obstructive jaundice. The age of the patients ranged from II to 80 (mean and SD:45.5±16) years and majority 29 (63%) were males. The cause of obstructive jaundice in these patients was choledocholithiasis (n=31), benign biliary stricture (n=8), post cholecystectomy recurrent stones (n=3), carcinoma of pancreas (n=3) and papillary stenosis (n=I). Endoscopic Sphincterotomy (ES) was technically successful in all the 46 patients and brought prompt symptomatic relief in 43 patients. Sixteen patients (34.8%) required additional drainage such as stenting or nasobiliary drain. In patients with chohidocholithiasis, bile duct could be cleared of stones in 29 (93.5%) patients and in two surgical removal was required. Of the remaining patients, surgery was required in 4 (50%) patients with benign biliary structure, in I (33.3%) of those with malignant stricture and none of the patients presenting with papillary stenosis or recurrent bile duct stones after cholecystectomy. Complications were seen in only two patients (4.4%): one had mild acute pancreatitis and another had GI bleed, which did not require blood transfusion. Both the complications were self-limiting. No procedure related deaths were noted. Endoscopic therapy, thus, a simple, effective and safe method of treatment in patients with choledocholithiasis and selected patients with malignant biliary obstruction. MJAFII998;
“…For example, most endoscopists now claim rates for successful extraction of stones of between 90 and 95% (Safrany, 1978;Roberts-Thomson, 1984). However, difficulties may arise with large stones, impacted stones, ampullary orifices located within duodenal diverticula and bile duct stones in patients who have previously been treated with a Billroth II gastrectomy.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.